Furthermore, some studies demonstrated that pharmacological increase in the phosphorylation of Akt and GSK3β protected against brain injuries induced by transient focal and global cerebral ischemia, and its neuroprotective effect was counteracted by administration of a PI3K inhibitor [24,54,55]. The gene discussed is GSK3B; the disease is brain ischemia.